These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 3014379)

  • 1. [Case reports of 77 HTLV III/LAV-positive patients observed during one-year period. Preliminary note].
    Soranzo ML; Salassa B; Daziano E; Paggi GC
    Minerva Med; 1986 May; 77(20):897-900. PubMed ID: 3014379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Laboratory results in the evaluation of anti HTLV-III in subjects at risk].
    Maschio C; Colangeli S; Rughetti A; Fonzi D; Barnabei R; Ciccarella A
    Riv Emoter Immunoematol; 1985; 32(3):302-6. PubMed ID: 3008301
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R; Redfield RR; Broder S
    J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key epidemiologic questions about AIDS and infection with HTLV-III/LAV.
    Hopkins DR
    Public Health Rep; 1986; 101(3):234-7. PubMed ID: 3012620
    [No Abstract]   [Full Text] [Related]  

  • 5. [Proof of diaplacental transmission of HTLV III/LAV before the 20th week of pregnancy].
    Schäfer A; Jovaisas E; Stauber M; Löwenthal D; Koch MA
    Geburtshilfe Frauenheilkd; 1986 Feb; 46(2):88-9. PubMed ID: 3007265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological trends of AIDS in the United States.
    Curran JW; Morgan WM; Starcher ET; Hardy AM; Jaffe HW
    Cancer Res; 1985 Sep; 45(9 Suppl):4602s-4604s. PubMed ID: 2990692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing for HTLV-III/LAV antibody.
    Holston JL
    Ala J Med Sci; 1986 Jul; 23(3):269-71. PubMed ID: 3019171
    [No Abstract]   [Full Text] [Related]  

  • 8. Milan as possible starting point of LAV/HTLV III epidemic among Italian drug addicts.
    Lazzarin A; Crocchiolo P; Galli M; Uberti Foppa C; Caredda F; Re T; Moroni M
    Boll Ist Sieroter Milan; 1987; 66(1):9-13. PubMed ID: 3304347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibodies against human T-cell leukemia virus (HTLV) in male homosexuals with acquired immunodeficiency syndrome].
    Kurth R; Brede HD; Bergmann L; Mitrou PS; Helm EB; Stille W
    MMW Munch Med Wochenschr; 1983 Dec; 125(48):1119-23. PubMed ID: 6318098
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
    Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
    Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
    [No Abstract]   [Full Text] [Related]  

  • 11. HTLV III infection and AIDS.
    Bingham JS
    Practitioner; 1985 Oct; 229(1408):869-75. PubMed ID: 2997767
    [No Abstract]   [Full Text] [Related]  

  • 12. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
    Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Increase in the prevalence of antibodies against LAV/HTLV III in drug addicts in West Germany].
    Zoulek G; Gürtler L; Eberle J; Lorbeer B; Deinhardt F
    Dtsch Med Wochenschr; 1986 Apr; 111(15):567-70. PubMed ID: 3007065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of antibodies against LAV/HTLV III: comparative evaluation of four different commercial test kits.
    Abb J
    AIDS Res; 1986; 2(2):93-7. PubMed ID: 3013224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HTLV-III serology, epidemiology and clinical aspects of imprisoned i.v. drug-dependent males in Austria].
    Pont J; Neuwald C; Kunz C; Werdenich W
    Wien Klin Wochenschr; 1986 Jul; 98(14):454-7. PubMed ID: 3019019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HTLV-III and HTLV-I infection in populations at risk in the Veneto region of Italy.
    De Rossi A; Gassa OD; del Mistro A; Faulkner Valle G; Bianchi LC
    Eur J Cancer Clin Oncol; 1986 Apr; 22(4):411-8. PubMed ID: 3015630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kaposi sarcoma in acquired immune deficiency syndrome (AIDS). I: Clinical findings and laboratory diagnosis].
    Weidauer H; Hofmann H
    Laryngol Rhinol Otol (Stuttg); 1985 Aug; 64(8):418-22. PubMed ID: 2995739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Before you test a patient for AIDS.... Ohio Department of Health recommendations for clinical management of individuals with HTLV-3 infection.
    Ohio State Med J; 1986 Aug; 82(8):533-7. PubMed ID: 3018646
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevalence of antibodies against HTLV-III/LAV in homosexuals and drug addicts from a population in Madrid].
    Alós JI; Rodríguez-Créixems M; Guerrero A; Gómez-Criado C; Romero-Vivas J; Bouza E
    Rev Clin Esp; 1986 Sep; 179(4):172-4. PubMed ID: 3464056
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-HTLV III/LAV antibodies of the IgM class in subjects at risk with negative anti-HTLV III/LAV IgG ELISA results (preliminary results)].
    Bedarida G; D'Agostino F; Ronsivalle MG; Berto E; Cambiè G; Berto N; Grisi ME; Arcidiacono I; Sterza G
    Riv Emoter Immunoematol; 1986; 33(1):75-87. PubMed ID: 3532290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.